Who Owns KTTAW?

Pasithea Therapeutics Corp. Warrants — Institutional Ownership & 13F Holdings

$0.01

+0.00 (+0.00%)

Market Cap

$76K

Shares Outstanding

7,442,153

Institutional Holders

5

Total Inst. Value

$1.0M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

New Positions

1

Closed Positions

1

Increased

0

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1CLEAR STREET LLC$1.0M71
2Kepos Capital LP$6K334,600
3Warberg Asset Management LLC$2K100,000
4ARMISTICE CAPITAL, LLC$91050,000
5SUSQUEHANNA INTERNATIONAL GROUP, LLPNew$19310,579

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
SUSQUEHANNA INTERNATIONAL GROUP, LLPNew+11K$193

Top Sellers

FundShares RemovedValue
Warberg Asset Management LLC-155K$2K

Related Stocks

Frequently Asked Questions

How many institutional investors hold KTTAW?

As of Q1 2025, 5 institutional investors report holding KTTAW (Pasithea Therapeutics Corp. Warrants) in their 13F filings.

Which hedge fund owns the most KTTAW?

The largest institutional holder of KTTAW is CLEAR STREET LLC with $1.0M in shares.

Are institutions buying or selling KTTAW?

This quarter, 1 institutions opened new positions in KTTAW and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.